StockData
ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc. (CLPT) stock

CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3012% above fair value
$7.86−0.44 (-5.30%)

Close on Nov 17, 2026Market cap $251.95MP/E –Yield –

ClearPoint Neuro price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

ClearPoint Neuro's price to sales ratio was 6.6× on Nov 11, 2026, against 12.0× a year earlier. Over the last 5 years it ranged from 5.6× to 19.6×, with a median of 10.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20266.6×−4.7
2025Dec 31, 202511.3×−2.6
2024Dec 31, 202413.9×+6.5
2023Dec 29, 20237.5×−3.1
2022Dec 30, 202210.6×−5.7
2021Dec 31, 202116.3×−4.2
2020Dec 31, 202020.5×+13.5
2019Dec 31, 20197.0×+4.4
2018Dec 31, 20182.6×−1.3
2017Dec 29, 20173.9×+1.7
2016Dec 30, 20162.2×−4.9
2015Dec 31, 20157.0×−5.8
2014Dec 31, 201412.8×−5.6
2013Dec 31, 201318.4×−0.7
2012Dec 31, 201219.0×–

More ClearPoint Neuro figures

See a number that looks wrong?